RNA Processing in Cardiac Hypertrophy: Coordinating Physiological Adaptation and Pathological Remodeling
The FASEB Journal · 2026
DOI: 10.1096/fj.202503525r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, 2026. Verfasst von Mengling Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Cardiomegaly, RNA Processing, Post-Transcriptional, Adaptation, Physiological. Die Arbeit nennt 142 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Cardiac hypertrophy represents a complex remodeling process involving extensive reprogramming of gene expression. While transcriptional regulation has been well characterized, post‐transcriptional RNA processing has recently emerged as a crucial determinant of cardiac homeostasis. This review summarizes current knowledge of RNA modifications, alternative splicing, mRNA stability, and RNA editing in physiological and pathological hypertrophy. We highlight key epitranscriptomic marks such as N6‐methyladenosine (m 6 A), 5‐methylcytosine (m 5 C), and 7‐methylguanosine (m 7 G), as well as the functions of RNA‐binding proteins and adenosine deaminases acting on RNA (ADAR1/2). In exercise‐induced hypertrophy, RNA processing contributes to adaptive remodeling by supporting sarcomere organization, calcium handling, and survival pathways, exemplified by RBFOX2‐dependent splicing of CACNA1C, RBM20‐directed regulation of titin isoforms, and METTL14‐mediated m 6 A signaling that enhances Akt activity. Conversely, pathological stress leads to dysregulated RNA programs that promote maladaptive remodeling through aberrant splice variants, perturbation of circular RNAs, and persistent pro‐inflammatory signaling, thereby facilitating contractile dysfunction and progression to heart failure. Context‐dependent regulators, including METTL3, YTHDF2, RBM24, and ADAR2, orchestrate the balance between adaptive and maladaptive responses. Targeting specific nodes, such as METTL3‐driven m 6 A methylation or RBM24‐dependent splicing fidelity, may provide innovative therapeutic strategies. Advances in RNA‐targeted interventions, including ADAR‐mediated editing and small molecule inhibitors of methyltransferases, highlight the translational potential of RNA processing as a novel avenue for precision cardiovascular therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Hospital of Jilin University, Changchun, China.
- China-Japan Union Hospital of Jilin University, Changchun, China.
ORCID-Profile: Yu Fu, Shanshan Zhou
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Peng, M., Fu, Y., Qin, C., Jin, J., & Zhou, S. (2026). RNA Processing in Cardiac Hypertrophy: Coordinating Physiological Adaptation and Pathological Remodeling. The FASEB Journal. https://doi.org/10.1096/fj.202503525r
Vancouver
Peng M, Fu Y, Qin C, Jin J, Zhou S. RNA Processing in Cardiac Hypertrophy: Coordinating Physiological Adaptation and Pathological Remodeling. The FASEB Journal. 2026. doi:10.1096/fj.202503525r
BibTeX
@article{Peng2026,
author = {Peng, Mengling and Fu, Yu and Qin, Cong and Jin, Jingpeng and Zhou, Shanshan},
title = {RNA Processing in Cardiac Hypertrophy: Coordinating Physiological Adaptation and Pathological Remodeling},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202503525r}
}
EUVIMED